Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | FABP4 | P15090 | 1/20 | 0.36 |
| ▸ | PGK1 | P00558 | 1/20 | 0.35 |
| ▸ | PGK2 | P07205 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | FKBP4 | Q02790 | 1/20 | 0.35 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | NPC1 | O15118 | 3/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | FASN | P49327 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9720603 | 0.83 | KMT2A (0.50) | MEN1KMT2APGK1PGK2FKBP4 | |
| SCHEMBL11360578 | 0.81 | GSK3B (0.42) | KMT2ALMNAALDH1A1NPC1RAB9A | |
| SCHEMBL11364813 | 0.81 | GSK3B (0.43) | PGK1PGK2FASN | |
| SCHEMBL14435878 | 0.78 | KMT2A (0.34) | MEN1KMT2ANPC1RAB9AKDM4E | |
| SCHEMBL26096892 | 0.78 | PLA2G2A (0.32) | MEN1KMT2APGK1PGK2FASN | |
| SCHEMBL9352415 | 0.78 | KMT2A (0.50) | MEN1KMT2AFABP4LMNAALDH1A1 | |
| SCHEMBL5996573 | 0.78 | FASN (0.37) | MEN1KMT2AFABP4PGK1PGK2 | |
| SCHEMBL11053483 | 0.75 | MEN1 (0.51) | MEN1KMT2ALMNAALDH1A1RAB9A | |
| SCHEMBL1259455 | 0.74 | LDHA (0.34) | FABP4PGK1PGK2LMNAALDH1A1 | |
| SCHEMBL3735175 | 0.74 | CYP3A4 (0.47) | MEN1KMT2ALMNANPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230137820-A1 | PHOSPHORESCENT aNHC-BASED PLATINUM (II) COMPLEXES | Technische Universität Dresden (DE) | 2023-05-04 | — | — | US | disclosed |
| EP-3717495-A1 | PHOSPHORESCENT PLATINUM (II) ANHC COMPLEXES | Technische Universität Dresden (DE) | 2020-10-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230137820-A1 | PHOSPHORESCENT aNHC-BASED PLATINUM (II) COMPLEXES | NDC1, ORC3, NUDC | MEN1 1752/4885KMT2A 2343/4885FABP4 1444/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.